Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

Clinical trial NCT07043608 · RECRUITING

Trial details

NCT number: NCT07043608
Sponsor: Kelly Fitzgerald, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Cancer (ccRCC)Clear Cell Renal Carcinoma Clear Cell Renal Cell Carcinoma Metastatic Clear Cell Renal Cancer Bone Metastases of a Malignant Tumor Clear Cell Renal Cell Carcinoma Bone, Metastatic Cancer Metastatic Cancer Metastatic Renal Cell Carcinoma Metastases to Bone

Start date: 2026-06-10
Primary completion: 2029-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.